Addex Therapeutics Ltd. (ADXN) Invested Capital (2022 - 2024)

Addex Therapeutics' Invested Capital history spans 3 years, with the latest figure at $11.0 million for Q4 2024.

  • For Q4 2024, Invested Capital rose 755.45% year-over-year to $11.0 million; the TTM value through Dec 2024 reached $11.0 million, up 755.45%, while the annual FY2024 figure was $11.0 million, 762.48% up from the prior year.
  • Invested Capital for Q4 2024 was $11.0 million at Addex Therapeutics, up from $1.3 million in the prior quarter.
  • Across five years, Invested Capital topped out at $11.0 million in Q4 2024 and bottomed at $1.3 million in Q4 2023.
  • The 3-year median for Invested Capital is $5.1 million (2022), against an average of $5.8 million.
  • The largest annual shift saw Invested Capital plummeted 74.68% in 2023 before it surged 755.45% in 2024.
  • A 3-year view of Invested Capital shows it stood at $5.1 million in 2022, then tumbled by 74.68% to $1.3 million in 2023, then soared by 755.45% to $11.0 million in 2024.
  • Per Business Quant, the three most recent readings for ADXN's Invested Capital are $11.0 million (Q4 2024), $1.3 million (Q4 2023), and $5.1 million (Q4 2022).